H.C. Wainwright Reiterates Buy Rating on Bionomics (BNOX), 'positioned well for further positive clinical data readouts'
Tweet Send to a Friend
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating and $8.00 price target on Bionomics Ltd. (NASDAQ: BNOX).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
